Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

Details for Australian Patent Application No. 2003247826 (hide)

Owner The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services University of Massachusetts

Inventors Bourgeois, Christelle; Stevens, Linda; Bortell, Rita; Moss, Joel

Agent Griffith Hack

Pub. Number AU-B-2003247826

PCT Number PCT/US03/20498

PCT Pub. Number WO2004/003195

Priority 60/393,033 28.06.02 US

Filing date 27 June 2003

Wipo publication date 19 January 2004

Acceptance publication date 24 April 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 1/107 (2006.01) General processes for the preparation of peptides

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 9/10 (2006.01) Enzymes, e.g. ligases (6.) - Transferases (2.)

C12N 15/55 (2006.01) Mutation or genetic engineering - Hydrolases (3)

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12Q 1/48 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving transferase

Event Publications

2 October 2003 Complete Application Filed

  Priority application(s): 60/393,033 28.06.02 US

4 March 2004 Application Open to Public Inspection

  Published as AU-B-2003247826

10 March 2005 Amendment Made

  The nature of the amendment is: Amend the name of the applicant to The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services. 2003248504 SK Chemicals Co., Ltd. The nature of the amendment is: Amend the name of the applicant to SK Chemicals Co., Ltd. 2003248558 CV Therapeutics, Inc. The nature of the amendment is: Amend the invention title to read Method of treating diabetes

3 April 2008 Assignment before Grant

  The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services; University of Massachusetts Medical Center The application has been assigned to The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services; University of Massachusetts

24 April 2008 Application Accepted

  Published as AU-B-2003247826

21 August 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003247827-METHODS TO ASSESS QUALITY OF MICROARRAYS

2003247825-Use of tellurium in carbon supported noble metal containing catalysts for liquid phase oxidation reactions